<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211650</url>
  </required_header>
  <id_info>
    <org_study_id>ACP-HA</org_study_id>
    <nct_id>NCT03211650</nct_id>
  </id_info>
  <brief_title>Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis</brief_title>
  <official_title>Efficacy of Intra-articular Injection of Combined Hyaluronic Acid and Platelet-rich Plasma in Knee Degenerative Joint Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Regen Lab SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of intra-articular injections of&#xD;
      combined hyaluronic acid and platelet-rich plasma in knee degenerative joint disease in&#xD;
      improving joint function and reducing pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 14, 2016</start_date>
  <completion_date type="Actual">March 27, 2021</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WOMAC score</measure>
    <time_frame>6 months after the first intra-articular injection</time_frame>
    <description>Comparison of WOMAC total score among three treatment arms</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>hyaluronic acid + platelet-rich plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-articular injections of hyaluronic acid combined with platelet-rich plasma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>platelet-rich plasma</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-articular injections of platelet-rich plasma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hyaluronic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-articular injections of hyaluronic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyaluronic Acid + platelet-rich plasma</intervention_name>
    <description>Intra-articular injections of hyaluronic acid combined with platelet-rich plasma</description>
    <arm_group_label>hyaluronic acid + platelet-rich plasma</arm_group_label>
    <other_name>Cellular Matrix/A-CP HA Kit</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyaluronic acid</intervention_name>
    <description>Intra-articular injections of hyaluronic acid</description>
    <arm_group_label>hyaluronic acid</arm_group_label>
    <other_name>ArthroVisc40</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>platelet-rich plasma</intervention_name>
    <description>Intra-articular injections of platelet-rich plasma</description>
    <arm_group_label>platelet-rich plasma</arm_group_label>
    <other_name>RegenKit-BCT-1</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Knee pain for 4 months;&#xD;
&#xD;
          -  Knee degenerative sign evaluated with X-ray with a Kellgren-Lawrence grade inferior to&#xD;
             3;&#xD;
&#xD;
          -  Patients able to understand the study conditions and willing to participate for its&#xD;
             entire duration;&#xD;
&#xD;
          -  Patients who signed written informed consent.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Severe knee osteoarthritis of grade 4;&#xD;
&#xD;
          -  Diabetes mellitus;&#xD;
&#xD;
          -  Rheumatoid arthritis;&#xD;
&#xD;
          -  Ongoing malignancies;&#xD;
&#xD;
          -  Certified allergic reactions towards the administered drugs ;&#xD;
&#xD;
          -  Malalignment of mechanical axis of the lower limb (varus &gt; 10 °, valgus &gt; 10 °);&#xD;
&#xD;
          -  Coagulopathies;&#xD;
&#xD;
          -  Severe cardiovascular diseases;&#xD;
&#xD;
          -  Ongoing infections;&#xD;
&#xD;
          -  Immunodepression;&#xD;
&#xD;
          -  Anticoagulants or anti-platelet agents;&#xD;
&#xD;
          -  Haemoglobin &lt; 11 g/dl;&#xD;
&#xD;
          -  Platelet count &lt; 150,000/mm^3&#xD;
&#xD;
          -  Drug addiction;&#xD;
&#xD;
          -  Alcoholism;&#xD;
&#xD;
          -  Psychiatric disease;&#xD;
&#xD;
          -  Pregnancy or breastfeeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pietro Randelli, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini - CTO</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U.O.C. 1a Divisione, Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO</name>
      <address>
        <city>Milano</city>
        <state>Milan</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <state>Milan</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>July 6, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Pietro Randelli, MD</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

